Reporter brief
STING inhibitor H-151 extended lifespan and reduced aging phenotypes in progeroid mice.
What happened
Researchers studied the LMNA-CK2α-STING signaling axis in aging using mouse models of progeria. Pharmacologic STING inhibition (H-151) in vivo rescued progeroid phenotypes including bone density loss and multi-tissue senescence, and extended lifespan. The authors found that controlled attenuation of STING signaling was more effective than complete STING ablation.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- Limitations have not been recorded; consult the primary source.
Study design and sample
Preclinical; Animal.
Progeroid mouse models; myeloid cells
- Design
- Preclinical
- Sample
- —
- Journal
- Nature Communications
- Published
- Aug 19, 2026
Effect size
Lifespan extension (specific magnitude not quantified in abstract); rescue of bone density loss and multi-tissue senescence
Caveats
- Assessment: Pending.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Senolytics timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.